University Hospitals Sussex NHS Foundation Trust - Worthing Hospital

The University Hospitals Sussex NHS Foundation Trust - Worthing Hospital incorporates Worthing Hospital https://www.uhsussex.nhs.uk/
Chemotherapy toxicity data combined with University Hospitals Sussex NHS Foundation Trust - St Richards Hospital with 76% of the data coded to Worthing Hospital.

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Advanced disease services:
    • Dedicated Specialist Advanced MDT
  • Support service facilities:
    • Dedicated nurses for ERAS services
    • Availability of 24 hour palliative care advice

Data Quality
All Patients: Trust Network National
Number of patients in Audit 238 2057 35779
Case ascertainment (%) Good Good Good
Data completeness of:
– Pre-treatment TNM (%) 58 84 86
– Performance status (%) 96 89 89
Patients having major resection: Trust Network National
Number of patients in Audit 121 1091 19631
ASA grade 1 (%) 21 10 9
ASA grade 2 (%) 50 59 53
ASA grade 3 (%) 19 26 31
ASA grade 4+ (%) 1 1 2
ASA grade not recorded (%) 9 3 4
Data completeness of:
7 Audit items for risk-adjustment (%) 77 90 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients
All Patients: Trust Network National
Number of patients in Audit 238 2057 35779
Seen by Clinical Nurse Specialist (%) 88 89 88

Management of patients having major resection
Patients having major resection: Trust Network National
Number of patients in Audit 121 1091 19614
Distant metastases (%) 2 3 5
Urgent or emergency surgery (%) 13 15 15
At least 12 lymph nodes excised (%) 77 84 84
Laparoscopic surgery attempted (%) 95 84 72
Risk-adjusted length of stay > 5 days (%) 46 49 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 63 N/A 10747
Adjuvant chemotherapy (%) 56 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit 46 N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) 6 N/A 22

Rectal cancer patients
Patients having major resection: Trust Network National
Number of patients in Audit 17 N/A 4251
Neoadjuvant therapy (%) 39 N/A 33
Circumferential resection margin: Recorded (%) 71 86 89
Circumferential resection margin: Negative (%) 71 80 83
Rectal volume 16 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 101 1092 19644
APER/Hartmanns (%) 35 29 37

Compare trust outcomes

Copyright © 2025 National Bowel Cancer Audit | Lovingly Crafted by Mixd